ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

Fred Hutchinson Director Lee Hartwell To Retire Next Year; Board Begins Search

July 3, 2009

Indoor Tanning Industry Funded Author Of NEJM Review On Vitamin D Deficiency.

April 18, 2008

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977

Bristol-Myers Adds Georgetown, MSK to Program

May 1, 1981

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992